Filing Details

Accession Number:
0001610618-22-000078
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-13 18:48:08
Reporting Period:
2022-09-12
Accepted Time:
2022-09-13 18:48:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1610618 Cidara Therapeutics Inc. CDTX Biological Products, (No Disgnostic Substances) (2836) 461537286
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1870270 Leslie Tari 6310 Nancy Ridge Drive
Suite 101
San Diego CA 92121
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-09-12 18,159 $0.68 193,741 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,298 Indirect By spouse
Footnotes
  1. Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on September 10, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
  2. Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2022.